Kathryn Mau
Optometrist · Honolulu, HINPI 1316146897
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $6,623 of the $7,678 with a category attached, or 86.3%. It is spread thinly across 21 manufacturers, the largest accounting for just 18.7% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $1,512, 4.4 times the $341 reported in 2019. Among optometrist clinicians in HI with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 269 payments — averaging $28.54 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Glaukos Corporation$1K
- Alcon$1K
- Dompe US, Inc.$781
- Sun Pharmaceutical Industries Inc.$678
- Amgen$666
- Novartis$508
- plus $2K from 15 others
What the payments were for
- Consulting fees$1,05514%
- Food & beverage$6,62386%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Glaukos Corporation | 11 | $1,434 |
| Alcon | 28 | $1,265 |
| Dompe US, Inc. | 31 | $781 |
| Sun Pharmaceutical Industries Inc. | 27 | $678 |
| Amgen(2 entities) | 22 | $666 |
| Novartis | 27 | $508 |
| Bausch & Lomb Americas Inc. | 27 | $443 |
| Bausch & Lomb, A Division Of Bausch Health US, LLC | 21 | $287 |
| Kala Pharmaceuticals, Inc. | 12 | $243 |
| AbbVie(2 entities) | 6 | $223 |
| Tarsus Pharmaceuticals, Inc. | 13 | $193 |
| Oyster Point Pharma, Inc. | 6 | $170 |
| Harrow Eye, LLC | 5 | $166 |
| Shire North American Group Inc | 14 | $156 |
| Aerie Pharmaceuticals, Inc. | 2 | $133 |
| Eyevance Pharmaceuticals LLC | 7 | $106 |
| Rxsight Inc | 2 | $74 |
| Johnson & Johnson Surgical Vision, Inc. | 2 | $53 |
| Mallinckrodt Hospital Products Inc. | 3 | $46 |
| Sight Sciences, Inc. | 2 | $35 |
| Staar Surgical Company | 1 | $18 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Photrexa$1,210
- Clareon PanOptix Pro$294
- Clareon$278
- TEPEZZA$273
- KXL System$155
- WaveLight EX500 Excimer Laser$145
- VUITY$124
- Oxervate$117
- Rocklatan$110
- Rhopressa$110
How this compares
$7,678 in reported general payments places this provider in the 90th percentile of 310 optometrist providers in Hawaii.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| MieboPerfluorohexyloctane/Pf | 66 | $49,589 |
| RestasisCyclosporine | 45 | $48,703 |
| CequaCyclosporine | 29 | $27,242 |
| Cyclosporine | 15 | $12,040 |
| Latanoprost | 147 | $3,342 |
| Timolol Maleate | 32 | $587 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Bausch & Lomb Americas Inc.Miebo | $443 | $49,58966 claims |
| AbbVieRestasis | $223 | $48,70345 claims |
| Sun Pharmaceutical Industries Inc.Cequa | $678 | $27,24229 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 310 optometrist providers in Hawaii.
Other optometrist in Honolulu
- Patricia IchimuraHonolulu$11K
- Lillian TakamuraHonolulu$11K
- Cherilyn LaiHonolulu$10K
- Brian TeruyaHonolulu$9K
- Derrick AbeHonolulu$9K
- Jennifer TeruyaHonolulu$9K
- Malia KuniokaHonolulu$9K
- Leslie PoonHonolulu$8K
- Chris YamamotoHonolulu$8K
- Rodney FongHonolulu$8K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.